National Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20892-4878, USA.
National Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Blvd., Bethesda, MD 20892-4878, USA.
Trends Mol Med. 2018 Nov;24(11):919-930. doi: 10.1016/j.molmed.2018.08.004. Epub 2018 Sep 10.
The promise of tissue engineering and regenerative medicine to reduce the burden of disease and improve quality of life are widely acknowledged. Traditional tissue engineering and regenerative medicine approaches rely on generation of tissue constructs in vitro for subsequent transplantation or injection of exogenously manipulated cells into a host. While promising, few such therapies have succeeded in clinical practice. Here, we propose that recent advances in stem cell and developmental biology, immunology, bioengineering, and material sciences, position us to develop a new generation of in vivo regenerative medicine therapies, which we term autotherapies. Autotherapies are strategies based on optimizing endogenous tissue responses and capitalizing on manipulation of stem cell niches and endogenous tissue microenvironments to enhance tissue healing and regeneration.
组织工程和再生医学有望减轻疾病负担、提高生活质量,这一点已得到广泛认可。传统的组织工程和再生医学方法依赖于体外生成组织构建体,然后将其移植或注射到宿主中。尽管这些方法很有前景,但在临床实践中,很少有此类疗法取得成功。在这里,我们提出,干细胞和发育生物学、免疫学、生物工程和材料科学的最新进展使我们能够开发新一代的体内再生医学疗法,我们称之为自疗法。自疗法是基于优化内源性组织反应的策略,并利用干细胞龛和内源性组织微环境的操纵来增强组织修复和再生。